Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arrakis Therapeutics
Biotech
EMD Serono taps in new commercial strategy head—Chutes & Ladders
EMD Serono taps in a new commercial strategy head. New Sanofi CEO swaps out research chief. RevMed R&D leader readies for retirement.
Darren Incorvaia
,
Zoey Becker
Jun 26, 2026 8:30am
RNA-targeting drug relaxes muscles in myotonic dystrophy mice
Dec 4, 2024 7:00am
BMS, Merck KGa in protein degradation race with Amphista pacts
May 4, 2022 8:00am
Amgen teams up with Arrakis in $75M RNA-destroying research deal
Jan 11, 2022 9:00am
'Leadership is showing': Biotech execs detail being openly LGBTQ
Dec 7, 2021 7:00am
Advent raises $215M to nurture another troop of biotechs
Feb 18, 2021 2:00am
